TherapeuticsMD Inc. (TXMD)
NASDAQ: TXMD
· Real-Time Price · USD
1.17
0.02 (1.72%)
At close: Aug 15, 2025, 3:58 PM
1.18
0.86%
After-hours: Aug 15, 2025, 07:44 PM EDT
TherapeuticsMD Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -555K | -2.2M | -2.35M | -4.01M | -4.87M | -6.2M | -7.7M | -39.38M | -66.91M | 47.78M | 1.07M | -8.66M | -27.12M | -182.05M | -172.41M | -171.54M | -156.73M | -166.06M |
Depreciation & Amortization | 387K | 471K | 509K | 1.05M | 1.08M | 1.03M | 922K | -1.7M | -797K | 120K | 1.19M | 4.18M | 4.18M | 4.17M | 4.09M | 4.12M | 4.11M | 4.08M |
Stock-Based Compensation | 81K | 176K | 264K | 356K | 557K | 899K | 1.27M | 4.14M | 8.21M | 9.99M | 11.57M | 13.93M | 16.94M | 17.23M | 18.13M | 14.96M | 10.78M | 11.27M |
Other Working Capital | 1.58M | 2.35M | 1.33M | -2M | -6.73M | -8.21M | -8.41M | -13.03M | -22.68M | -3.42M | -4.2M | -2.95M | 9.22M | -2.66M | 5.27M | 19.57M | 21M | 10.15M |
Other Non-Cash Items | -714K | 489K | 1.02M | 265K | 695K | -259K | -951K | 97.58M | 103.58M | -31.6M | -13.83M | -109.3M | -113.56M | 23.27M | 7.49M | 14.14M | 13.1M | 12.19M |
Deferred Income Tax | n/a | n/a | n/a | -2.06M | -2.06M | -2.06M | -2.06M | n/a | n/a | n/a | n/a | -7K | 88K | 303K | 533K | -4.07M | -3.66M | 2.11M |
Change in Working Capital | 1.7M | 2.47M | 1.56M | -2.46M | -8.1M | -10.4M | -17.45M | -18.99M | -15.33M | -9.55M | -4.09M | -3.55M | -3.24M | 3.24M | -520K | 8.94M | 3.13M | -22.32M |
Operating Cash Flow | 899K | 1.41M | 737K | -7.12M | -12.96M | -17.25M | -25.96M | 41.65M | 28.76M | 16.75M | -4.08M | -103.41M | -122.71M | -133.84M | -142.69M | -133.46M | -129.28M | -158.74M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -37K | -68K | -143K | -355K | -1.83M | -1.98M | -2M | -2.22M | -1.2M | -1.28M | -1.59M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -142.63M | -142.63M | n/a | n/a | 142.63M | 142.63M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 223.83M | 223.71M | 223.8M | 223.63M | -1.72M | -1.85M | -1.98M | -2.19M | -710K | -707K | -624K |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 81.16M | 81.13M | 223.69M | 223.48M | 140.8M | 140.65M | -2M | -2.22M | -1.24M | -1.32M | -1.59M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -94.43M | -94.43M | -214.43M | -219.43M | -125M | -125M | -5M | -50M | -50M | -50M | -50M |
Common Stock Repurchased | n/a | n/a | n/a | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 2M | 2M | 3.15M | 4.26M | -35K | -750K | -1.9M | -3.01M | -596K | -12K | 253K | -4.7M | 26.89M | 27.02M | 26.75M |
Financial Cash Flow | n/a | n/a | n/a | 2M | 2M | 3.15M | 4.26M | -109.69M | -107.95M | -229.1M | -235.21M | -121.91M | -91.83M | 28.6M | 129.55M | 159.9M | 128.19M | 127.85M |
Net Cash Flow | 837K | 1.41M | 732K | -5.12M | -8.5M | -12.91M | -44.99M | -28.16M | -23.82M | -13.14M | -15.8M | -66.51M | -73.87M | -107.23M | -15.36M | 25.21M | -2.42M | -32.48M |
Free Cash Flow | 1.03M | 1.54M | 851K | -7.01M | -12.96M | -17.25M | -25.96M | 41.61M | 28.69M | 16.6M | -4.43M | -105.24M | -124.69M | -135.84M | -144.92M | -134.66M | -130.57M | -160.33M |